Abstract
Primary lung tumors, breast tumors, and melanoma metastasize mainly in the brain where therapy is limited to surgery and radiation. To investigate the molecular basis of brain metastases, we isolated brain-trophic metastatic MDA-MB-435-LvBr2 (LvBr2) cells via left ventricle (LV) injection of MDA-MB-435 cells into immunodeficiency (NOD/SCID) mice. Whereas parent MDA-MB-435 cells displayed an elongated morphology, LvBr2 cells were round and displayed an aggregated distribution. LvBr2 cells expressed lower β-catenin levels and higher heterogeneous nuclear ribonucleoprotein C1/C2 (hnRNPC) levels than parental cells. Since microRNAs are known to play an important role in cancer progression including metastasis, we screened microRNAs expressed specifically in brain metastases. MicroRNA-146a was almost undetectable in LvBr2 cells and highly expressed in the parental cells. Overexpression of miR-146a increased β-catenin expression and suppressed the migratory and invasive activity of LvBr2 cells. The miR-146a-elicited decrease in hnRNPC in turn lowered the expression of MMP-1, uPA, and uPAR and inhibited the migratory and invasive activity of LvBr2 cells. Taken together, our findings indicate that miR-146a is virtually absent from brain metastases and can suppress their metastatic potential including their migratory and invasive activities associated with upregulation of β-catenin and downregulation of hnRNPC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aigner, A. (2011). MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasisrelated miRNAs. J. Mol. Med. 89, 445–457.
Akslen, L.A., Hove, L.M., and Hartveit, F. (1987). Metastatic distribution in malignant melanoma. A 30-year autopsy study. Invasion Metastasis 7, 253–263.
Arozarena, I., Bischof, H., Gilby, D., Belloni, B., Dummer, R., and Wellbrock, C. (2011). In melanoma, beta-catenin is a suppressor of invasion. Oncogene 30, 4531–4543.
Bhandary, Y.P., Velusamy, T., Shetty, P., Shetty, R.S., Idell, S., Cines, D.B., Jain, D., Bdeir, K., Abraham, E., Tsuruta, Y., et al. (2009). Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury. Am. J. Respir. Crit. Care Med. 179, 288–298.
Bhaumik, D., Scott, G.K., Schokrpur, S., Patil, C.K., Campisi, J., and Benz, C.C. (2008). Expression of microRNA-146 suppres-ses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 5643–5647.
Bos, P.D., Zhang, X.H., Nadal, C., Shu, W., Gomis, R.R., Nguyen, D.X., Minn, A.J., van de Vijver, M.J., Gerald, W.L., Foekens, J.A., et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005–1009.
Chambers, A.F., Groom, A.C., and MacDonald, I.C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563–572.
Chien, A.J., Moore, E.C., Lonsdorf, A.S., Kulikauskas, R.M., Rothberg, B.G., Berger, A.J., Major, M.B., Hwang, S.T., Rimm, D.L., and Moon, R.T. (2009). Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc. Natl. Acad. Sci. USA 106, 1193–1198.
Christian, K.J., Lang, M.A., and Raffalli-Mathieu, F. (2008). Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment. Mol. Pharmacol. 73, 1558–1567.
Deng, J., Miller, S.A., Wang, H.Y., Xia, W., Wen, Y., Zhou, B.P., Li, Y., Lin, S.Y., and Hung, M.C. (2002). beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2, 323–334.
Giles, R.H., van Es, J.H., and Clevers, H. (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1–24.
Gould Rothberg, B.E., Berger, A.J., Molinaro, A.M., Subtil, A., Krauthammer, M.O., Camp, R.L., Bradley, W.R., Ariyan, S., Kluger, H.M., and Rimm, D.L. (2009). Melanoma prognostic model using tissue microarrays and genetic algorithms. J. Clin. Oncol. 27, 5772–5780.
Hurst, D.R., Edmonds, M.D., and Welch, D.R. (2009). Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res. 69, 7495–7498.
Li, Y., Vandenboom, T.G., 2nd, Wang, Z., Kong, D., Ali, S., Philip, P.A., and Sarkar, F.H. (2010). miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 70, 1486–1495.
Maelandsmo, G.M., Holm, R., Nesland, J.M., Fodstad, O., and Florenes, V.A. (2003). Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin. Cancer Res. 9, 3383–3388.
Nam, D.H., Jeon, H.M., Kim, S., Kim, M.H., Lee, Y.J., Lee, M.S., Kim, H., Joo, K.M., Lee, D.S., Price, J.E., et al. (2008). Activation of notch signaling in a xenograft model of brain metastasis. Clin. Cancer Res. 14, 4059–4066.
Nguyen, D.X., Bos, P.D., and Massague, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274–284.
Nicoloso, M.S., Spizzo, R., Shimizu, M., Rossi, S., and Calin, G.A. (2009). MicroRNAs—the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293–302.
Price, J.E., Polyzos, A., Zhang, R.D., and Daniels, L.M. (1990). Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50, 717–721.
Qiao, M., Sheng, S., and Pardee, A.B. (2008). Metastasis and AKT activation. Cell Cycle 7, 2991–2996.
Shetty, S. (2005). Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells. Mol. Cell. Biochem. 272, 107–118.
Xiao, B., Zhu, E.D., Li, N., Lu, D.S., Li, W., Li, B.S., Zhao, Y.L., Mao, X.H., Guo, G., Yu, P.W., et al. (2012). Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol. Rep. 27, 559–566.
Author information
Authors and Affiliations
Corresponding authors
Additional information
These authors contributed equally to this work.
About this article
Cite this article
Hwang, S.J., Seol, H.J., Park, Y.M. et al. MicroRNA-146a suppresses metastatic activity in brain metastasis. Mol Cells 34, 329–334 (2012). https://doi.org/10.1007/s10059-012-0171-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-012-0171-6